Status:

COMPLETED

Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Salience Level (Expt 1.1)

Lead Sponsor:

University of California, Santa Barbara

Collaborating Sponsors:

National Eye Institute (NEI)

Conditions:

Basic Science: Visual Attention in Healthy Participants

Basic Science: Neural Representations of Location

Eligibility:

All Genders

18-55 years

Phase:

NA

Brief Summary

How does one know what to look at in a scene? Imagine a "Where's Waldo" game - it's challenging to find Waldo because there are many 'salient' locations in the picture, each vying for one's attention....

Detailed Description

In this experiment, participants will engage in all task conditions in a repeated-measures design. Participants are not randomly assigned to groups, as all participants will experience the same set of...

Eligibility Criteria

Inclusion

  • between 18 and 55 years of age
  • normal or corrected-to-normal vision

Exclusion

  • neurological disease based on self-report
  • implanted medical devices (e.g., cardiac pacemaker; metallic aneurism clip)
  • non-removable metallic piercings
  • metal fragments in the body (e.g., from welding)
  • pregnant and have a chance of being pregnant (if female)
  • history of claustrophobia
  • history of hearing loss/damage

Key Trial Info

Start Date :

April 25 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 31 2025

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT06175312

Start Date

April 25 2024

End Date

January 31 2025

Last Update

May 23 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California, Santa Barbara

Santa Barbara, California, United States, 93117

Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Salience Level (Expt 1.1) | DecenTrialz